| Product NDC: | 0065-0543 |
| Proprietary Name: | TRIESENCE |
| Non Proprietary Name: | triamcinolone acetonide |
| Active Ingredient(s): | 40 mg/mL & nbsp; triamcinolone acetonide |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0065-0543 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022048 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101001 |
| Package NDC: | 0065-0543-01 |
| Package Description: | 1 mL in 1 VIAL, GLASS (0065-0543-01) |
| NDC Code | 0065-0543-01 |
| Proprietary Name | TRIESENCE |
| Package Description | 1 mL in 1 VIAL, GLASS (0065-0543-01) |
| Product NDC | 0065-0543 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | triamcinolone acetonide |
| Dosage Form Name | INJECTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20101001 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |